$16.61+1.9%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 3, 2026
Company outlook: revenue of $1.2B to $1.3B for Fiscal year 2026 — up 6.7% on a year earlier
Just reported
From Sotera Health Company's results release of November 3, 2026; its quarterly report has since been filed.
Actual
$324.9M
+4.4% y/y
+1.1% q/q
Guided
—
No guide given
Actual
$0.20
+18% y/y
+5.3% q/q
Guided
—
No guide given
Full year 2026
| Measure | 3 months toSep 30, 2026 | 3 months toSep 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $324.9M | $311.3M | +4.36% |
| Profit | $58.4M | $48.4M | +20.64% |
| Profit per share | $0.20 | $0.17 | +17.65% |
| Free Cash Flow | $57.7M | $35M | +64.98% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Sotera Health Company reported on November 3, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
“We are pleased with our third-quarter performance, which included solid top- and bottom-line constant currency growth, along with nearly 100 basis points of sequential Adjusted EBITDA margin expansion,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®. Updates on recent developments in matters relevant to investors can be found on the
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Sotera Health Company’s Item 2.02 8-K filed November 3, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.